When it comes to losing weight, some people will stop at nothing to give themselves the perfect waistline, including strict diets, regular exercise and even surgery.
However that all may become a thing of the past as scientists from the University of Bonn in Germany have reportedly developed a drug that "sets fat on fire," changing the game for people who are interested in losing weight.
Without getting too technical, the new drug apparently works by promoting the production of more healthy "brown fat" and less unhealthy "white fat."
The main issue with white fat is that it soaks up calories and stores them in the abdomen and thighs, increasing the risk of heart disease and diabetes.
The scientists in Germany found during their research that a particular enzyme, known as soluble guanylate cyclase, triggers the conversion of food into more brown fat and less white fat.
Early experiments with the enzyme showed that mice who were treated with it released higher levels of soluble guanylate cyclase, which in turn formed more brown fat.
Scientists in Britain have welcomed the new discovery, like professor Tom Sanders, expert in nutrition and diet at King's College London, who said:
This is a potentially important study as it suggests a mechanism that can set "fat on fire." There has been a lot of renewed interest in the browning of adipose tissue and the findings have relevance to type 2 diabetes risk because it is excess white fat that is associated with type 2 diabetes. However, this study was done in mice where brown adipose tissue plays a much more important role in maintaining energy balance than humans. It also remains to be seen whether the drug has any adverse effects on blood pressure, as this has been a problem with some other candidate drugs.
[Image credit: hiit-blog.dailyhiit.com]